series-a
Stage
1
Investors
About
Syngoi Technologies is a contract development and manufacturing organization specializing in synthetic DNA production using patented enzymatic cell-free methods to support advanced cell and gene therapies.
Explore Syngoi's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.